Subscribe to RSS
DOI: 10.1055/a-2642-0854
Trends in Medicare Reimbursement for the Resection of Vestibular Schwannomas: 2000 to 2021

Abstract
Objectives
Current procedural terminology (CPT) for the surgical removal of vestibular schwannoma (VS) has been inconsistently applied due to the redundant plurality of coding possibilities. This report analyzes reimbursement rates between different CPT strategies to determine if financial incentives may be a potential driver of this divergent behavior.
Methods
Medicare Part B National Summary files were queried for reimbursement data concerning VS resections from 2000 to 2021. Data were categorized by CPT codes for approach, excision, or combination codes encompassing both elements for three surgical approaches: middle fossa, translabyrinthine, and retrosigmoid (RS). Separated approach and excision codes were bundled in a pairwise fashion to imitate real-world billing practices. Inflation-adjusted data was curated according to the consumer price index and further analyzed by compound annual growth rate. Utilization trends were measured using gross allowed services.
Results
Inflation-adjusted fees declined for all services. However, some services, namely piecemeal RS codes, experienced nominal payment increases that dampened inflationary value erosion. Intragroup assessment proved RS to be the most popular and best compensated approach within both the pairwise and combination groups. Intergroup assessment proved the RS combination code was most frequently employed overall, with the pairwise RS approach and excision bundle collecting the greatest average reimbursement.
Conclusion
This study suggests the divergence in CPT assignment for surgically managed VS is likely driven, in part or in whole, by financial incentive and indicates the need for fiscal reform, or an erasure of redundant CPT, to unify CPT application.
Keywords
reimbursement - Medicare - vestibular schwannoma - acoustic neuroma - CPT - translabyrinthine - middle fossa - retrosigmoidContributors' Statement
This manuscript is the original work of the authors listed and is not under consideration by any other publishing outlet.
Note
This study was previously presented as an oral presentation at the North American Skull Base Society (NASBS) meeting.
Informed Consent
This study utilized publicly available government data, and thus was exempt from any requirement for IRB approval and/or individual consent.
Publication History
Received: 10 December 2024
Accepted: 23 June 2025
Article published online:
15 July 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Kohan D, Downey LL, Lim J, Cohen NL, Elowitz E. Uncommon lesions presenting as tumors of the internal auditory canal and cerebellopontine angle. Am J Otol 1997; 18 (03) 386-392
- 2 Chamoun R, MacDonald J, Shelton C, Couldwell WT. Surgical approaches for resection of vestibular schwannomas: translabyrinthine, retrosigmoid, and middle fossa approaches. Neurosurg Focus 2012; 33 (03) E9
- 3 Bi WL, Mooney MA, Yoon S. et al. Variation in coding practices for vestibular schwannoma surgery. J Neurol Surg B Skull Base 2019; 80 (01) 96-102
- 4 Patel VA, Dunklebarger M, Banerjee K, Shokri T, Zhan X, Isildak H. Surgical management of vestibular schwannoma: practice pattern analysis via NSQIP. Ann Otol Rhinol Laryngol 2020; 129 (03) 230-237
- 5 Roehm P, Nelson R, Wiet M, Stevens S. Controversy in coding for vestibular schwannoma surgery [op-ed]. AAO-HNS Bulletin. 2023 . Accessed February 16, 2024 at: https://bulletin.entnet.org/clinical-patient-care/article/22872770/controversy-in-coding-for-vestibular-schwannoma-surgery
- 6 Pollock K. Variation in coding practices for vestibular schwannoma surgery. J Neurol Surg B Skull Base 2019; 80 (01) 103-104
- 7 Centers for Medicare & Medicaid Services. Dataset Downloads. CMS. Accessed July 23, 2023 at: https://www.cms.gov/priorities/key-initiatives/open-payments/data/dataset-downloads
- 8 Smith S. A quantitative analysis of integrated reporting via CAGR on publicly traded U.S. corporations listed in the S & P 500. Theor Econ Lett 2018; 8 (08) 1443-1459
- 9 Chaij JM, Hammond JB, Palmer SK. et al. Is the future of cleft care financially sustainable? An economic analysis of inflation-adjusted reimbursements. Cleft Palate Craniofac J 2025 ;10556656251322608
- 10 Honarpisheh P, Parker SL, Conner CR. et al. 20-year inflation-adjusted Medicare reimbursements (years: 2000-2020) for common lumbar and cervical degenerative disc disease procedures. Global Spine J 2024; 14 (01) 211-218